Providence Health & Services Washington
Providence Health & Services Washington was paid $78.40M by Medicaid between Jan 2018 and Dec 2024, across 341 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
SPOKANE, WA 99204
Next to other Social Worker providers in Washington
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 233,805 | $10.69M | |
| 2019 | 227,042 | $10.79M | |
| 2020 | 193,367 | $9.05M | |
| 2021 | 212,125 | $10.48M | |
| 2022 | 223,891 | $12.45M | |
| 2023 | 256,534 | $13.23M | |
| 2024incomplete | 218,032 | $11.70M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 331,740 | 320,004 | $23.12M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 272,945 | 264,920 | $15.42M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.7% | 51,505 | 47,623 | $6.04M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.7% | 108,567 | 35,240 | $3.71M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.4% | 72,983 | 28,425 | $3.43M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.2% | 26,050 | 25,900 | $2.54M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.8% | 24,010 | 23,236 | $2.19M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.1% | 17,191 | 17,112 | $1.65M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.9% | 12,019 | 11,899 | $1.49M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 19,479 | 19,273 | $1.42M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.2% | 15,294 | 13,477 | $913K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.1% | 8,653 | 8,571 | $839K |
329 more codes
| 99205 | Prolong outpt/office vis | 1.0% | 5,068 | $792K |
| G9149 | National committee for quality assurance - level 2 medical home | <1% | 3,780 | $652K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 9,785 | $546K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 4,611 | $544K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 9,214 | $539K |
| 99223 | Prolong inpt eval add15 m | <1% | 5,033 | $428K |
| 90837 | Psychotherapy session, about an hour | <1% | 5,052 | $412K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 9,351 | $397K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,666 | $379K |
| 90686 | <1% | 24,055 | $359K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 522 | $334K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 5,322 | $318K |
| 99245 | <1% | 2,454 | $308K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 2,519 | $280K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 3,709 | $273K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 4,540 | $262K |
| 99243 | <1% | 3,177 | $260K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 4,644 | $250K |
| 76821 | <1% | 4,516 | $211K | |
| 95886 | <1% | 2,645 | $185K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,359 | $184K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,596 | $182K |
| 96112 | <1% | 2,383 | $182K | |
| 76820 | <1% | 7,040 | $178K | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 3,086 | $171K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 3,407 | $165K |
| 90670 | <1% | 12,112 | $163K | |
| 76825 | <1% | 1,069 | $161K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,889 | $159K |
| 93000 | <1% | 16,943 | $158K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,357 | $158K |
| 95819 | <1% | 1,851 | $156K | |
| 99460 | <1% | 1,732 | $144K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 16,898 | $141K |
| 93320 | <1% | 9,272 | $141K | |
| 95251 | <1% | 7,353 | $135K | |
| 59025 | Fetal non-stress test | <1% | 4,139 | $132K |
| 99255 | <1% | 1,084 | $130K | |
| 95720 | <1% | 1,441 | $129K | |
| 97803 | <1% | 3,089 | $121K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,269 | $113K |
| 90961 | <1% | 2,438 | $107K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,443 | $104K |
| 96040 | <1% | 2,984 | $103K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 27,026 | $101K |
| 93304 | <1% | 2,805 | $97K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,641 | $95K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,386 | $87K |
| 64721 | <1% | 431 | $86K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 2,022 | $81K |
| 95951 | <1% | 557 | $80K | |
| 96131 | <1% | 679 | $80K | |
| 93325 | <1% | 18,438 | $76K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 3,260 | $72K |
| 92551 | <1% | 9,900 | $72K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,417 | $71K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 407 | $70K |
| 59514 | <1% | 463 | $66K | |
| 97165 | <1% | 1,364 | $65K | |
| 96101 | <1% | 511 | $64K | |
| 90680 | <1% | 4,638 | $64K | |
| 97802 | <1% | 963 | $63K | |
| 94729 | <1% | 3,546 | $62K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,406 | $60K |
| 96127 | <1% | 16,663 | $58K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,384 | $57K |
| 20611 | <1% | 1,255 | $56K | |
| 94060 | <1% | 2,770 | $55K | |
| 94726 | <1% | 3,180 | $53K | |
| 95782 | <1% | 508 | $50K | |
| 43235 | <1% | 928 | $49K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 567 | $48K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 1,365 | $48K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 508 | $47K |
| 99284 | Emergency room visit (serious) | <1% | 925 | $46K |
| 92567 | <1% | 4,939 | $46K | |
| 99220 | <1% | 722 | $46K | |
| 96130 | <1% | 697 | $44K | |
| 99463 | <1% | 447 | $44K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 533 | $44K |
| 76827 | <1% | 1,088 | $44K | |
| 43244 | <1% | 362 | $43K | |
| 76813 | <1% | 631 | $43K | |
| 92557 | <1% | 1,899 | $37K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,008 | $37K |
| 96111 | <1% | 535 | $37K | |
| 93321 | <1% | 5,920 | $36K | |
| 90698 | <1% | 3,106 | $36K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 6,206 | $35K |
| D0120 | Dental checkup, returning patient | <1% | 1,408 | $35K |
| 99173 | <1% | 20,293 | $34K | |
| 76818 | <1% | 490 | $34K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 6,452 | $33K |
| 94010 | <1% | 2,218 | $33K | |
| 90633 | <1% | 2,773 | $32K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 1,667 | $32K |
| 29916 | <1% | 60 | $31K | |
| 73140 | <1% | 2,057 | $31K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 154 | $29K |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 238 | $29K |
| 87631 | <1% | 230 | $29K | |
| 90697 | <1% | 1,484 | $29K | |
| 99254 | <1% | 277 | $28K | |
| 76801 | <1% | 408 | $27K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,122 | $27K |
| 73610 | <1% | 2,135 | $26K | |
| 95806 | <1% | 964 | $26K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,709 | $26K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,931 | $26K |
| 73100 | <1% | 1,958 | $26K | |
| 95816 | <1% | 475 | $25K | |
| 92610 | <1% | 477 | $25K | |
| G9150 | National committee for quality assurance - level 3 medical home | <1% | 366 | $25K |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 999 | $24K |
| 92526 | <1% | 461 | $23K | |
| 90688 | <1% | 1,712 | $22K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 660 | $22K |
| 95909 | <1% | 307 | $22K | |
| 95911 | <1% | 178 | $22K | |
| 73630 | <1% | 1,863 | $22K | |
| 31231 | <1% | 205 | $21K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 190 | $21K |
| 90648 | <1% | 2,054 | $21K | |
| 73564 | <1% | 1,314 | $20K | |
| 99354 | <1% | 246 | $20K | |
| 99283 | Emergency room visit (moderate) | <1% | 575 | $19K |
| 99443 | <1% | 312 | $18K | |
| 73030 | <1% | 1,508 | $18K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 68 | $18K |
| 73502 | <1% | 938 | $16K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,504 | $16K |
| 80305 | <1% | 1,498 | $16K | |
| 54161 | <1% | 137 | $15K | |
| 90677 | <1% | 914 | $14K | |
| 90685 | <1% | 1,202 | $14K | |
| 99383 | <1% | 136 | $14K | |
| 90870 | <1% | 397 | $14K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 138 | $13K |
| 69210 | <1% | 701 | $13K | |
| 73130 | <1% | 820 | $13K | |
| 43259 | <1% | 150 | $13K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 105 | $13K |
| 31237 | <1% | 63 | $12K | |
| 31575 | <1% | 194 | $12K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 262 | $12K |
| 95717 | <1% | 251 | $11K | |
| 29848 | <1% | 41 | $11K | |
| 92652 | <1% | 145 | $10K | |
| 96161 | <1% | 4,853 | $10K | |
| 87800 | <1% | 262 | $10K | |
| 90723 | <1% | 765 | $9K | |
| 95885 | <1% | 178 | $9K | |
| 95117 | <1% | 1,371 | $9K | |
| 96136 | <1% | 404 | $9K | |
| 92587 | <1% | 704 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,145 | $9K |
| 99285 | Emergency room visit (most serious) | <1% | 237 | $8K |
| 99219 | <1% | 104 | $8K | |
| 73110 | <1% | 524 | $8K | |
| 90744 | <1% | 765 | $8K | |
| 45390 | <1% | 50 | $8K | |
| 93531 | <1% | 30 | $7K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 168 | $7K |
| 92555 | <1% | 426 | $7K | |
| 99499 | <1% | 242 | $7K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 41,141 | $7K |
| 92552 | <1% | 356 | $7K | |
| 36416 | <1% | 3,259 | $7K | |
| 80053 | Comprehensive metabolic panel | <1% | 611 | $6K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 81 | $6K |
| 96137 | <1% | 184 | $6K | |
| 99152 | <1% | 856 | $6K | |
| 99429 | <1% | 233 | $6K | |
| 93296 | <1% | 454 | $6K | |
| 43248 | <1% | 94 | $6K | |
| 80050 | General health panel | <1% | 156 | $6K |
| 95910 | <1% | 49 | $5K | |
| 80061 | Lipid panel | <1% | 398 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 620 | $5K |
| 99442 | <1% | 139 | $5K | |
| 90651 | <1% | 452 | $5K | |
| D0330 | Panoramic radiographic image | <1% | 171 | $5K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 289 | $5K |
| 95874 | <1% | 218 | $5K | |
| 92579 | <1% | 172 | $5K | |
| 83655 | <1% | 396 | $5K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 162 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 265 | $5K |
| 92504 | <1% | 313 | $5K | |
| 64615 | <1% | 81 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 583 | $5K |
| 59430 | <1% | 27 | $5K | |
| 99462 | <1% | 133 | $5K | |
| 29824 | <1% | 26 | $5K | |
| 90656 | <1% | 1,201 | $5K | |
| 99382 | <1% | 42 | $4K | |
| 81003 | <1% | 2,297 | $4K | |
| G9148 | National committee for quality assurance - level 1 medical home | <1% | 17 | $4K |
| 30520 | <1% | 12 | $4K | |
| 94664 | <1% | 401 | $4K | |
| 73562 | <1% | 331 | $4K | |
| 46221 | <1% | 30 | $4K | |
| 20610 | <1% | 141 | $4K | |
| 46600 | <1% | 53 | $4K | |
| 93224 | <1% | 61 | $3K | |
| 93308 | <1% | 126 | $3K | |
| 95115 | <1% | 470 | $3K | |
| 43251 | <1% | 37 | $3K | |
| 99201 | <1% | 100 | $3K | |
| 93294 | <1% | 162 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 76 | $3K |
| 95811 | <1% | 49 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 76 | $3K |
| 99292 | <1% | 42 | $3K | |
| 76882 | <1% | 59 | $3K | |
| 90480 | <1% | 97 | $3K | |
| 90962 | <1% | 92 | $2K | |
| 84703 | <1% | 294 | $2K | |
| 93923 | <1% | 55 | $2K | |
| 90710 | <1% | 166 | $2K | |
| 26055 | <1% | 14 | $2K | |
| 99493 | <1% | 16 | $2K | |
| 90734 | <1% | 235 | $2K | |
| 99384 | <1% | 16 | $2K | |
| 64644 | <1% | 42 | $2K | |
| 95024 | <1% | 24 | $2K | |
| 99497 | <1% | 66 | $2K | |
| D1110 | Prophylaxis - adult | <1% | 30 | $2K |
| 90696 | <1% | 137 | $2K | |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | <1% | 70 | $2K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 512 | $2K |
| 85018 | <1% | 706 | $2K | |
| 29826 | <1% | 26 | $2K | |
| 90715 | <1% | 131 | $1K | |
| 99253 | <1% | 20 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 178 | $1K |
| 99177 | <1% | 465 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 73 | $1K |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 187 | $1K |
| 81001 | <1% | 390 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 58 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 135 | $1K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 35 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 23 | $1K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 85 | $1K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 31 | $1K |
| 95027 | <1% | 24 | $1K | |
| 90619 | <1% | 76 | $1K | |
| 99242 | <1% | 20 | $1K | |
| 94618 | <1% | 102 | $1K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 83 | $1K |
| 74328 | <1% | 91 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 289 | $1K |
| 90672 | <1% | 64 | $979.23 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 37 | $935.66 |
| V5264 | Ear mold/insert, not disposable, any type | <1% | 27 | $911.49 |
| 30140 | <1% | 12 | $901.03 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 12 | $877.70 |
| 95908 | <1% | 12 | $818.80 | |
| 81002 | <1% | 255 | $777.50 | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 60 | $772.80 |
| 90707 | <1% | 73 | $765.42 | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 13 | $740.28 |
| 93227 | <1% | 51 | $722.59 | |
| 97760 | <1% | 30 | $717.60 | |
| 90700 | <1% | 66 | $677.99 | |
| 95012 | <1% | 64 | $619.41 | |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes) | <1% | 30 | $619.26 |
| 85027 | <1% | 83 | $583.39 | |
| 90674 | <1% | 22 | $564.89 | |
| 29075 | <1% | 13 | $530.32 | |
| 92626 | <1% | 13 | $505.86 | |
| 95970 | <1% | 54 | $505.20 | |
| 99441 | <1% | 19 | $492.31 | |
| 95813 | <1% | 12 | $478.14 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 63 | $449.83 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 18 | $442.17 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 15 | $439.77 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 32 | $438.12 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 61 | $417.92 |
| 20550 | <1% | 17 | $416.30 | |
| 92556 | <1% | 15 | $393.85 | |
| 99188 | <1% | 33 | $391.14 | |
| D0274 | Bitewings - four radiographic images | <1% | 24 | $376.29 |
| 93244 | <1% | 25 | $372.73 | |
| 90474 | <1% | 427 | $361.36 | |
| 90716 | <1% | 38 | $355.39 | |
| 82607 | <1% | 16 | $250.04 | |
| 96415 | <1% | 13 | $232.86 | |
| 73552 | <1% | 14 | $224.23 | |
| 73120 | <1% | 16 | $215.25 | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 76 | $208.59 |
| 36591 | <1% | 14 | $206.98 | |
| 86803 | <1% | 15 | $192.84 | |
| 0001A | <1% | 61 | $172.78 | |
| 90687 | <1% | 19 | $166.48 | |
| D9420 | <1% | 33 | $145.05 | |
| 76937 | <1% | 25 | $141.98 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 112 | $136.55 |
| 90461 | <1% | 22,377 | $127.82 | |
| 96160 | <1% | 54 | $101.44 | |
| 0012A | <1% | 13 | $86.59 | |
| 0002A | <1% | 29 | $85.17 | |
| 85652 | <1% | 29 | $83.73 | |
| 81025 | <1% | 12 | $76.69 | |
| 86140 | <1% | 13 | $73.97 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 30 | $32.53 |
| 99417 | Prolong home eval add 15m | <1% | 13 | $24.47 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $23.07 |
| 99072 | <1% | 2,113 | $10.50 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 28 | $6.64 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 37 | $3.29 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 14 | $0.14 |
| 3078F | 0% | 16,389 | $0.00 | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 1,030 | $0.00 |
| 99358 | Prolong nursin fac eval 15m | 0% | 15 | $0.00 |
| 90473 | 0% | 82 | $0.00 | |
| 3077F | 0% | 97 | $0.00 | |
| 91308 | 0% | 12 | $0.00 | |
| 3080F | 0% | 98 | $0.00 | |
| 3074F | 0% | 22,258 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 698 | $0.00 |
| 1036F | 0% | 3,238 | $0.00 | |
| 3079F | 0% | 1,129 | $0.00 | |
| S9982 | Medical records copying fee, per page | 0% | 195 | $0.00 |
| S9981 | Medical records copying fee, administrative | 0% | 219 | $0.00 |
| H0049 | Alcohol and/or drug screening | 0% | 357 | $0.00 |
| 91307 | 0% | 12 | $0.00 | |
| 3075F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.